Expression of complement system components during aging and amyloid deposition in APP transgenic mice

Journal of Neuroinflammation

Volumn 6, Issue , 2009, Pages

  Reichwald, Julia ^a   Danner, Simone ^a   Wiederhold, Karl Heinz ^a   Staufenbiel, Matthias ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; AMYLOID; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C5; MESSENGER RNA; AMYLOID BETA PROTEIN; ISOPROTEIN;

AGE DISTRIBUTION; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; C57BL 6 MOUSE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; IMMUNOHISTOLOGY; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; WESTERN BLOTTING; ALZHEIMER DISEASE; ANIMAL; BRAIN; C57BL MOUSE; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; COMPLEMENT ACTIVATION; COMPLEMENT C1Q; COMPLEMENT C3; COMPLEMENT C4; COMPLEMENT C5; FEMALE; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTEIN ISOFORMS; RNA, MESSENGER;

EID: 71049194870     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-6-35     Document Type: Article

References (41)

1. Goldsby RA, Kindt TJ, Osborne BA, Kuby J. Immunology 2003, New York: W.H. Freeman and Company.
2. Barnum SR. Complement biosynthesis in the central nervous system. Crit Rev Oral Biol Med 1995, 6:132-146. 10.1177/10454411950060020301, 7548620.
3. Morgan BP, Gasque P. Expression of complement in the brain: role in health and disease. Immunol Today 1996, 17:461-466. 10.1016/0167-5699(96)20028-F, 8908810.
4. Shen Y, Li R, McGeer EG, McGeer PL. Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain. Brain Res 1997, 769:391-395. 10.1016/S0006-8993(97)00850-0, 9374212.
5. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol Aging 2000, 21:383-421. 10.1016/S0197-4580(00)00124-X, 10858586.
6. Shen Y, Meri S. Yin and Yang: complement activation and regulation in Alzheimer's disease. Prog Neurobiol 2003, 70:463-472.
7. Tenner AJ. Complement in Alzheimer's disease: opportunities for modulating protective and pathogenic events. Neurobiol Aging 2001, 22:849-861. 10.1016/S0197-4580(01)00301-3, 11754992.
8. Shen Y, Lue L, Yang L, Roher A, Kuo Y, Strohmeyer R, Goux WJ, Lee V, Johnson GV, Webster SD, Cooper NR, Bradt B, Rogers J. Complement activation by neurofibrillary tangles in Alzheimer's disease. Neurosci Lett 2001, 305:165-168. 10.1016/S0304-3940(01)01842-0, 11403931.
9. Afagh A, Cummings BJ, Cribbs DH, Cotman CW, Tenner AJ. Localization and cell association of C1q in Alzheimer's disease brain. Exp Neurol 1996, 138:22-32. 10.1006/exnr.1996.0043, 8593893.
10. Brachova L, Lue LF, Schultz J, el Rashidy R, Rogers J. Association cortex, cerebellum, and serum concentrations of C1q and factor B in Alzheimer's disease. Brain Res Mol Brain Res 1993, 18:329-334. 10.1016/0169-328X(93)90097-9, 8326828.
11. Eikelenboom P, Hack CE, Rozemuller JM, Stam FC. Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Arch B Cell Pathol Incl Mol Pathol 1989, 56:259-262. 10.1007/BF02890024, 2565620.
12. Loeffler DA, Camp DM, Bennett DA. Plaque complement activation and cognitive loss in Alzheimer's disease. Journal of Neuroinflammation 2008, 5:9. 10.1186/1742-2094-5-9, 2292690, 18334032.
13. McGeer PL, Akiyama H, Itagaki S, McGeer EG. Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci Lett 1989, 107:341-346. 10.1016/0304-3940(89)90843-4, 2559373.
14. Terai K, Walker DG, McGeer EG, McGeer PL. Neurons express proteins of the classical complement pathway in Alzheimer disease. Brain Res 1997, 769:385-390. 10.1016/S0006-8993(97)00849-4, 9374211.
15. Webster S, Lue LF, Brachova L, Tenner AJ, McGeer PL, Terai K, Walker DG, Bradt B, Cooper NR, Rogers J. Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease. Neurobiol Aging 1997, 18:415-421. 10.1016/S0197-4580(97)00042-0, 9330973.
16. Yasojima K, Schwab C, McGeer EG, McGeer PL. Up-regulated production and activation of the complement system in Alzheimer's disease brain. Am J Pathol 1999, 154:927-936. 1866427, 10079271.
17. Salminen A, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T. Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol 2009, 87:181-194. 10.1016/j.pneurobio.2009.01.001, 19388207.
18. Bradt BM, Kolb WP, Cooper NR. Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide. J Exp Med 1998, 188:431-438. 10.1084/jem.188.3.431, 2212467, 9687521.
19. Jiang H, Burdick D, Glabe CG, Cotman CW, Tenner AJ. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J Immunol 1994, 152:5050-5059.
20. Rogers J, Cooper NR, Webster S, Schultz J, McGeer PL, Styren SD, Civin WH, Brachova L, Bradt B, Ward P. Complement activation by beta-amyloid in Alzheimer disease. Proc Natl Acad Sci USA 1992, 89:10016-10020. 10.1073/pnas.89.21.10016, 50268, 1438191.
21. Schwab C, Hosokawa M, McGeer PL. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease. Exp Neurol 2004, 188:52-64. 10.1016/j.expneurol.2004.03.016, 15191802.
22. Matsuoka Y, Picciano M, Malester B, Lafrancois J, Zehr C, Daeschner JM, Olschowka JA, Fonseca MI, O'Banion MK, Tenner AJ, Lemere CA, Duff K. Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease. Am J Pathol 2001, 158:1345-1354. 1891893, 11290552.
23. Webster SD, Tenner AJ, Poulos TL, Cribbs DH. The mouse C1q A-chain sequence alters beta-amyloid-induced complement activation. Neurobiol Aging 1999, 20:297-304. 10.1016/S0197-4580(99)00020-2, 10588577.
24. Li M, Ager RR, Fraser DA, Tjokro NO, Tenner AJ. Development of a humanized C1q A chain knock-in mouse: Assessment of antibody independent beta-amyloid induced complement activation. Molecular Immunology 2008, 45:3244-3252. 10.1016/j.molimm.2008.02.022, 2453780, 18400300.
25. Fonseca MI, Zhou J, Botto M, Tenner AJ. Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease. J Neurosci 2004, 24:6457-6465. 10.1523/JNEUROSCI.0901-04.2004, 15269255.
26. Maier M, Peng Y, Jiang L, Seabrook TJ, Carroll MC, Lemere CA. Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice. J Neurosci 2008, 28:6333-6341. 10.1523/JNEUROSCI.0829-08.2008, 18562603.
27. Wyss-Coray T, Yan F, Lin AH, Lambris JD, Alexander JJ, Quigg RJ, Masliah E. Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice. Proc Natl Acad Sci USA 2002, 99:10837-10842. 10.1073/pnas.162350199, 125059, 12119423.
28. DeMattos RB, O'Dell MA, Parsadanian M, Taylor JW, Harmony JA, Bales KR, Paul SM, Aronow BJ, Holtzman DM. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2002, 99:10843-10848. 10.1073/pnas.162228299, 125060, 12145324.
29. McLaughlin L, Zhu G, Mistry M, Ley-Ebert C, Stuart WD, Florio CJ, Groen PA, Witt SA, Kimball TR, Witte DP, Harmony JA, Aronow BJ. Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis. J Clin Invest 2000, 106:1105-1113. 10.1172/JCI9037, 301413, 11067863.
30. Fonseca MI, Ager RR, Chu SH, Yazan O, Sanderson SD, Laferla FM, Taylor SM, Woodruff TM, Tenner AJ. Treatment with a C5aR Antagonist Decreases Pathology and Enhances Behavioral Performance in Murine Models of Alzheimer's Disease. Journal of Immunology 2009, 183:1375-1383.
31. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, Ledermann B, Burki K, Frey P, Paganetti PA, Waridel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 1997, 94:13287-13292. 10.1073/pnas.94.24.13287, 24301, 9371838.
32. Ong GL, Mattes MJ. Mouse strains with typical mammalian levels of complement activity. J Immunol Methods 1989, 20(125):147-158.
33. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996, 6:986-994. 10.1101/gr.6.10.986, 8908518.
34. Applied B. Amplification Efficiency of TaqMan Gene Expression Assays. Applied Biosystems 2004,
35. Kim YU, Kinoshita T, Molina H, Hourcade D, Seya T, Wagner LM, Holers VM. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J Exp Med 1995, 181:151-159. 10.1084/jem.181.1.151, 2191854, 7528766.
36. Li B, Sallee C, Dehoff M, Foley S, Molina H, Holers VM. Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J Immunol 1993, 151:4295-4305.
37. Ong GL, Baker AE, Mattes MJ. Analysis of high complement levels in Mus hortulanus and BUB mice. J Immunol Methods 1992, 154:37-45. 10.1016/0022-1759(92)90210-K, 1401942.
38. Fan R, Tenner AJ. Differential regulation of Abeta42-induced neuronal C1q synthesis and microglial activation. J Neuroinflammation 2005, 2:1. 10.1186/1742-2094-2-1, 545941, 15642121.
39. Bornemann KD, Wiederhold KH, Pauli C, Ermini F, Stalder M, Schnell L, Sommer B, Jucker M, Staufenbiel M. Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice. Am J Pathol 2001, 158:63-73. 1850262, 11141480.
40. Osmers I, Szalai AJ, Tenner AJ, Barnum SR. Complement in BuB/BnJ mice revisited: serum C3 levels and complement opsonic activity are not elevated. Mol Immunol 2006, 43:1722-1725. 10.1016/j.molimm.2005.10.004, 16310250.
41. Strohmeyer R, Shen Y, Rogers J. Detection of complement alternative pathway mRNA and proteins in the Alzheimer's disease brain. Brain Res Mol Brain Res 2000, 81:7-18. 10.1016/S0169-328X(00)00149-2, 11000474.